News and Press Releases
Press releases
Theralase’s Lead Anti-Cancer Drug Has Significantly Less Skin Toxicity than FDA Approved Drug
Toronto, Ontario – February 13, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®), a developer of advanced Photo...
0Theralase Ranked in 2015 Toronto Stock Exchange Venture 50®
Toronto, Ontario – February 11, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has be...
0Theralase Files Health Canada Approval for Next Generation Therapeutic Laser
Toronto, Ontario – February 9, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has suc...
0Theralase Anti-Cancer Technology Research Accepted for Peer Reviewed Publication
Toronto, Ontario, February 3, 2015 /Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink(R)), a developer of advanced Photo Dyna...
0Theralase’s Latest Research on Anti-Cancer Technology Accepted for Presentation at International Conference
Toronto, Ontario, January 29, 2015 / Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink(R)) announced today that its latest res...
0Theralase Files US Patent Application for Increased Targeting of Photo Dynamic Therapy
Toronto, Ontario – January 20, 2015, Theralase Technologies Inc. (“Theralase”)(TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has file...
0Theralase Identifies Lead Photo Dynamic Compound for Human Clinical Trials
Toronto, Ontario – January 15, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has ide...
0Theralase to Present at Alpha North Investor Conference
Toronto, Ontario – January 13, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that Roger Dumo...
0Theralase Summarizes its 2014 Scientific Achievements and 2015 Strategic Objectives
Toronto, Ontario – January 9, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today a summary of its...
0Theralase Reports Results of PDC Therapy of Bladder Cancer in Orthotopic Rat Model
Toronto, Ontario – December 23, 2014, Theralase Technologies Inc. (“Theralase”)(TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has obt...
0in the news
BTv – Theralase® an innovative medical technology for bladder cancer treatment – 2018
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
